Search
Phathom Pharmaceuticals Inc
PHATAdd to Watchlist
8.930USD
+0.180+2.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
715.03MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Phathom Pharmaceuticals Inc is 8.55, ranking 28 out of 155 in the Pharmaceuticals industry. The average price target is 20.00, with a high of 29.00 and a low of 12.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
21.900
Target Price
+150.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Phathom Pharmaceuticals Inc
PHAT
11
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Phathom Pharmaceuticals Inc's expected revenue for the next quarter?
Phathom Pharmaceuticals Inc's expected revenue is 86.46M.
What is Phathom Pharmaceuticals Inc's price target?
Analysts forecast that Phathom Pharmaceuticals Inc's price target is USD 20.00, with the highest forecast at USD 29.00 and the lowest forecast at USD 12.00.
How have Phathom Pharmaceuticals IncPHAT's recent earnings per share performed?
The market expectation was USD -0.21, while Phathom Pharmaceuticals IncPHAT's earnings per share (EPS) for the previous quarter was USD -0.37. EPS for the next quarter is expected at USD -0.08.
What is the analyst rating for Phathom Pharmaceuticals Inc?
Based on the ratings of Phathom Pharmaceuticals Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.